SLDE · Slide Insurance Holdings, Inc. · Insider Trading

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock

These restricted stock units vest in 24 equal monthly installments commencing on January 1, 2025 and ending on December 31, 2026, subject to the Reporting Person's continued employment or service through each applicable vesting date.

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock

These restricted stock units vest in 24 equal monthly installments commencing on January 1, 2025 and ending on December 31, 2026, subject to the Reporting Person's continued employment or service through each applicable vesting date.

Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

The amount shown reflects the amount owned by the Reporting Person's spouse after the vesting of 22,918 restricted stock units on October 31, 2026 and the withholding of 9,019 shares of common stock for the payment of the tax liability associated therewith.

Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

The amount shown reflects the amount owned by the Reporting Person's spouse after the vesting of 22,918 restricted stock units on October 31, 2026 and the withholding of 9,019 shares of common stock for the payment of the tax liability associated therewith.

Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

These restricted stock units vest in 24 equal monthly installments commencing on January 1, 2025 and ending on December 31, 2026, subject to the Reporting Person's continued employment or service through each applicable vesting date.

Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

These restricted stock units vest in 24 equal monthly installments commencing on January 1, 2025 and ending on December 31, 2026, subject to the Reporting Person's continued employment or service through each applicable vesting date.

Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.

Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $27.50 to $27.62 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.

Of the 24,900 stock options reported herein, 11,150 are vested and exercisable. The remaining 13,750 vest on July 14, 2027.

Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.

Of the 27,500 stock options reported herein, 13,750 are vested and exercisable. The remaining 13,750 vest on July 14, 2027.

Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.

Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $27.50 to $27.61 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

These restricted stock units vest in 24 equal monthly installments commencing on January 1, 2025 and ending on December 31, 2026, subject to the Reporting Person's continued employment or service through each applicable vesting date.

Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

These restricted stock units vest in 24 equal monthly installments commencing on January 1, 2025 and ending on December 31, 2026, subject to the Reporting Person's continued employment or service through each applicable vesting date.

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock

These restricted stock units vest in 24 equal monthly installments commencing on January 1, 2025 and ending on December 31, 2026, subject to the Reporting Person's continued employment or service through each applicable vesting date.

Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock

These restricted stock units vest in 24 equal monthly installments commencing on January 1, 2025 and ending on December 31, 2026, subject to the Reporting Person's continued employment or service through each applicable vesting date.

The amount shown reflects the amount owned by the Reporting Person's spouse after the vesting of 22,919 restricted stock units on September 30, 2026 and the withholding of 9,019 shares of common stock for the payment of the tax liability associated therewith.

Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

The amount shown reflects the amount owned by the Reporting Person's spouse after the vesting of 22,919 restricted stock units on September 30, 2026 and the withholding of 9,019 shares of common stock for the payment of the tax liability associated therewith.

Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

These stock options are fully vested and exercisable.

Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.

Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $26.00 to $26.02 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.

Of the 38,874 stock options reported herein, 25,124 are vested and exercisable. The remaining 13,750 vest on July 14, 2027.

Sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.

Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $24.12 to $24.40 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

The securities reported herein are held by GRM Family Limited Partnership, which is an entity controlled by the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.

Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $24.15 to $24.65 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

The securities reported herein are held by GRM Family Limited Partnership, which is an entity controlled by the reporting person. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.

Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transactions ranges from $24.50 to $24.87 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price.

Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 4, 2026.

Of the 50,248 stock options reported herein, 36,498 are vested and exercisable. The remaining 13,750 vest on July 14, 2027.

Exercised and sold pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 15, 2025.

The amount shown reflects the amount owned by the Reporting Person's spouse after the vesting of 22,918 restricted stock units on August 31, 2026 and the withholding of 9,019 shares of common stock for the payment of the tax liability associated therewith.

Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock

These restricted stock units vest in 24 equal monthly installments commencing on January 1, 2025 and ending on December 31, 2026, subject to the Reporting Person's continued employment or service through each applicable vesting date.

The amount shown reflects the amount owned by the Reporting Person's spouse after the vesting of 22,918 restricted stock units on August 31, 2026 and the withholding of 9,019 shares of common stock for the payment of the tax liability associated therewith.

Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

These restricted stock units vest in 24 equal monthly installments commencing on January 1, 2025 and ending on December 31, 2026, subject to the Reporting Person's continued employment or service through each applicable vesting date.

Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

These restricted stock units vest in 24 equal monthly installments commencing on January 1, 2025 and ending on December 31, 2026, subject to the Reporting Person's continued employment or service through each applicable vesting date.

Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock

These restricted stock units vest in 24 equal monthly installments commencing on January 1, 2025 and ending on December 31, 2026, subject to the Reporting Person's continued employment or service through each applicable vesting date.

Represent shares of common stock beneficially owned by the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

These stock options are fully vested and exercisable.